355 related articles for article (PubMed ID: 18304774)
1. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
Babay HA
Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
[TBL] [Abstract][Full Text] [Related]
5. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.
Obritsch MD; Fish DN; MacLaren R; Jung R
Antimicrob Agents Chemother; 2004 Dec; 48(12):4606-10. PubMed ID: 15561832
[TBL] [Abstract][Full Text] [Related]
6. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
Pardo Serrano FJ; Tirado Balaguer MD; García Zúñiga ED; Granados Ortega J; Campos Aznar A; Moreno Muñoz R
Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
[TBL] [Abstract][Full Text] [Related]
8. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
Al-Jasser AM; Elkhizzi NA
Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011.
Walkty A; Baxter M; Adam H; Karlowsky JA; Lagacé-Wiens P; Hoban DJ; Zhanel GG
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):361-4. PubMed ID: 22694789
[TBL] [Abstract][Full Text] [Related]
14. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of 2906 Pseudomonasaeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: Results of the Canadian Ward surveillance study (CANWARD), 2008-2015.
Walkty A; Lagace-Wiens P; Adam H; Baxter M; Karlowsky J; Mulvey MR; McCracken M; Zhanel GG
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):60-63. PubMed ID: 28336136
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
[TBL] [Abstract][Full Text] [Related]
17. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
Hsueh PR; Tseng SP; Teng LJ; Ho SW
Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
[TBL] [Abstract][Full Text] [Related]
19. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.
Messadi AA; Lamia T; Kamel B; Salima O; Monia M; Saida BR
Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
Eagye KJ; Banevicius MA; Nicolau DP
Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
